The GSAS Harvard Biotech Club Presents: LION Biosciences: Information Integration -- New Economy in Life Sciences

Apr 02, 2001, 01:00 ET from GSAS Harvard Biotechnology Club

    BOSTON, April 2 /PRNewswire/ -- LION biosciences: Information Integration
 -- New Economy in Life Sciences
 
     Speaker:  Dr. Reinhard Schneider, CEO of US Operations
     Date: April 3
     Time: 5:00 PM
     Location: MEC Walter Amphitheater at the Medical Education Center
     (MEC), Harvard Medical School, Boston, MA
 
     LION bioscience aims to significantly and sustainably improve Life Science
 R&D performance and productivity through application and implementation of
 comprehensive and seamless information and knowledge management solutions that
 are based on a strong scientific basis and experience. These solutions span
 and integrate all disciplines in R&D, starting from genetics over early and
 late discovery into clinics. LION offers these solutions to partners
 throughout the whole life science industry in basically two main ways:
 1. i-biology: installation and implementation of an enterprise-wide horizontal
 information and knowledge management solution
 2. iD3: internal application of i-biology to the own nuclear receptor
 discovery program with the goal to out license specific databases,
 polymorphism  marker panels, and validated leads and targets.
 
     Founded in 1997, the company today has more than 400 employees, with
 headquarters in Heidelberg, Germany, and subsidiaries in Cambridge, UK,
 Cambridge, MA, and San Diego, CA. To date, LION has established  numerous
 partnerships with leading Life Science companies, including Aventis, Bayer,
 Boehringer Ingelheim, Celera, DuPont, Glaxo Wellcome, GMD, Janssen, Merck
 Inc., Nestle, Novartis, Paradigm Genetics, Pharmacia & Upjohn,  SmithKline
 Beecham, Sumitomo Pharmaceuticals and Tripos.
 
     Dr. Reinhard Schneider is a co-founder of LION and has been with the
 company since March 1997 as Vice President Bioinformatics. He now serves as
 the Chief Executive Officer of the US subsidiary LION Bioscience Research
 Inc., located in Cambridge, Massachusetts. As a scientist in the Biocomputing
 Department at the EMBL (European  Molecular Biology Laboratory), Dr. Schneider
 studied various aspects of protein structure  prediction and sequence
 alignment as well as the development of large scale automated sequence
 analysis and the use of massive parallel computers in biology. Dr. Schneider
 studied biology in Aachen and Heidelberg and received his Ph.D. in biology at
 the University of Heidelberg, Germany.
 
     About the GSAS Harvard Biotechnology Club: The GSAS Harvard Biotechnology
 Club is bridging the gap between the biotechnology industry and academia by
 educating its membership, over 1600 worldwide and growing. This non-profit
 student organization, founded in 1999 and based at the Harvard Medical School
 has a membership that includes professionals from a host of academic
 institutions and various industry sectors including biotechnology, consulting,
 law and venture capital.  The club sponsors a wide range of events including a
 seminar series featuring executives from biotechnology and related fields, an
 online magazine, a consulting group, an annual career fair, reviews emerging
 technologies, provides biotechnology start-up incubator resources and
 distributes to its members the Boston Biotechnology Bulletin, a weekly event
 calendar.
 
     To learn more about the Biotech Club's activities and become a member
 visit http://www.TheBiotechClub.org or contact Kim Seth, Managing Director,
 617-355-8397, kim@thebiotechclub.org.
 
 

SOURCE GSAS Harvard Biotechnology Club
    BOSTON, April 2 /PRNewswire/ -- LION biosciences: Information Integration
 -- New Economy in Life Sciences
 
     Speaker:  Dr. Reinhard Schneider, CEO of US Operations
     Date: April 3
     Time: 5:00 PM
     Location: MEC Walter Amphitheater at the Medical Education Center
     (MEC), Harvard Medical School, Boston, MA
 
     LION bioscience aims to significantly and sustainably improve Life Science
 R&D performance and productivity through application and implementation of
 comprehensive and seamless information and knowledge management solutions that
 are based on a strong scientific basis and experience. These solutions span
 and integrate all disciplines in R&D, starting from genetics over early and
 late discovery into clinics. LION offers these solutions to partners
 throughout the whole life science industry in basically two main ways:
 1. i-biology: installation and implementation of an enterprise-wide horizontal
 information and knowledge management solution
 2. iD3: internal application of i-biology to the own nuclear receptor
 discovery program with the goal to out license specific databases,
 polymorphism  marker panels, and validated leads and targets.
 
     Founded in 1997, the company today has more than 400 employees, with
 headquarters in Heidelberg, Germany, and subsidiaries in Cambridge, UK,
 Cambridge, MA, and San Diego, CA. To date, LION has established  numerous
 partnerships with leading Life Science companies, including Aventis, Bayer,
 Boehringer Ingelheim, Celera, DuPont, Glaxo Wellcome, GMD, Janssen, Merck
 Inc., Nestle, Novartis, Paradigm Genetics, Pharmacia & Upjohn,  SmithKline
 Beecham, Sumitomo Pharmaceuticals and Tripos.
 
     Dr. Reinhard Schneider is a co-founder of LION and has been with the
 company since March 1997 as Vice President Bioinformatics. He now serves as
 the Chief Executive Officer of the US subsidiary LION Bioscience Research
 Inc., located in Cambridge, Massachusetts. As a scientist in the Biocomputing
 Department at the EMBL (European  Molecular Biology Laboratory), Dr. Schneider
 studied various aspects of protein structure  prediction and sequence
 alignment as well as the development of large scale automated sequence
 analysis and the use of massive parallel computers in biology. Dr. Schneider
 studied biology in Aachen and Heidelberg and received his Ph.D. in biology at
 the University of Heidelberg, Germany.
 
     About the GSAS Harvard Biotechnology Club: The GSAS Harvard Biotechnology
 Club is bridging the gap between the biotechnology industry and academia by
 educating its membership, over 1600 worldwide and growing. This non-profit
 student organization, founded in 1999 and based at the Harvard Medical School
 has a membership that includes professionals from a host of academic
 institutions and various industry sectors including biotechnology, consulting,
 law and venture capital.  The club sponsors a wide range of events including a
 seminar series featuring executives from biotechnology and related fields, an
 online magazine, a consulting group, an annual career fair, reviews emerging
 technologies, provides biotechnology start-up incubator resources and
 distributes to its members the Boston Biotechnology Bulletin, a weekly event
 calendar.
 
     To learn more about the Biotech Club's activities and become a member
 visit http://www.TheBiotechClub.org or contact Kim Seth, Managing Director,
 617-355-8397, kim@thebiotechclub.org.
 
 SOURCE  GSAS Harvard Biotechnology Club